I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Munir, T
364
results:
Articles (Online) X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
STUDY OF GENETIC VARIABILITY IN CHICKPEA GERMPLASM AND ITS ..:
CHEEMA, KL
;
SARDAR, S
;
AMIN, MA
...
Biological and Clinical Sciences Research Journal. 2024 (2024) 1 - p. 798 , 2024
Link:
https://doi.org/10.54112..
?
2
SCREENING OF WHEAT GENOTYPES FOR WATER DEFICIT CONDITIONS U..:
SARWAR, MA
;
YAR, US
;
AMIN, HAB
...
Biological and Clinical Sciences Research Journal. 2024 (2024) 1 - p. 940 , 2024
Link:
https://doi.org/10.54112..
?
3
Richter's transformation: Transforming the clinical landsca..:
Barrett, A.
;
Appleby, N.
;
Dreau, H.
...
Blood Reviews. 64 (2024) - p. 101163 , 2024
Link:
https://doi.org/10.1016/..
?
4
OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FO..:
Fonseca, AR
;
Justino, CC
;
Molla, VC
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S17 , 2023
Link:
https://doi.org/10.1016/..
?
5
Ibrutinib (Ibr) dose modification for management of early c..:
Tedeschi, A.
;
Ahn, I. E.
;
Fraser, G. A. M.
...
Hematological Oncology. 41 (2023) S2 - p. 461-463 , 2023
Link:
https://doi.org/10.1002/..
?
6
DECIPHERING THE GENETIC CODES: GENE ACTION AND COMBINING AB..:
KHAN, Z
;
GUL, N
;
MEHBOOB, A
...
Biological and Clinical Sciences Research Journal. 2023 (2023) 1 - p. 569 , 2023
Link:
https://doi.org/10.54112..
?
7
Low dielectric loss, and enhanced magneto-dielectric proper..:
Rehman, Atta Ur
;
Sharif, Sehrish
;
Hegazy, H.H.
...
Materials Today Communications. 34 (2023) - p. 105371 , 2023
Link:
https://doi.org/10.1016/..
?
8
PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE ..:
Cheah, C. Y.
;
Shah, N. N.
;
Jurczak, W.
...
Hematological Oncology. 41 (2023) S2 - p. 153-156 , 2023
Link:
https://doi.org/10.1002/..
?
9
The evolving use of measurable residual disease in chronic ..:
Fisher, A.
;
Goradia, H.
;
Martinez-Calle, N.
..
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
10
ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN..:
Shadman, M.
;
Munir, T.
;
Roback, T.
...
Hematological Oncology. 41 (2023) S2 - p. 235-238 , 2023
Link:
https://doi.org/10.1002/..
?
11
PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE ..:
Shah, NN
;
Zinzani, PL
;
Eyre, TA
...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S359-S360 , 2023
Link:
https://doi.org/10.1016/..
?
12
Ibrutinib (Ibr) for treatment of relapsed‐refractory (R/R) ..:
Ghia, P.
;
Munir, T.
;
Burger, J.
...
Hematological Oncology. 41 (2023) S2 - p. 464-466 , 2023
Link:
https://doi.org/10.1002/..
?
13
S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS ..:
Hillmen, P.
;
Pitchford, A.
;
Bloor, A.
...
HemaSphere. 6 (2022) - p. 46-47 , 2022
Link:
https://doi.org/10.1097/..
?
14
S147: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVE..:
Mato, A. R.
;
Pagel, J. M.
;
Coombs, C. C.
...
HemaSphere. 6 (2022) - p. 48-49 , 2022
Link:
https://doi.org/10.1097/..
?
15
P673: DEPLETION AND RECOVERY OF NORMAL B-CELLS DURING AND A..:
Rawstron, A.
;
Webster, N.
;
Pitchford, A.
...
HemaSphere. 6 (2022) - p. 571-572 , 2022
Link:
https://doi.org/10.1097/..
1-15